Recent studies from our laboratory and others have emphasized the role of inflammation, and in particular adaptive immunity in hypertension. We have previously shown that various hypertensive stimuli, including angiotensin II, high salt and catecholamines cause T cell activation and entry of T cells with an effector phenotype into the vasculature and the kidney. Mice lacking T cells are protected against hypertension and much of the end-organ damage caused by these stimuli. Recently, we have found that CD8+ T cells are the subtype responsible for this effect, and our preliminary data show that chronic angiotensin II infusion stimulates CD8+ cells to produce the inflammatory cytokines IL-17 and IFN-g. We also have found that mice lacking these cytokines are partially protected against development of hypertension. In the present studies, we will further elucidate the mechanisms by which CD8+ cells are activated and cause hypertension.
In aim one we will employ adoptive transfer techniques to examine the effect of replenishing normal CD8+ cells or CD8+ cells lacking either IL-17 or IFN-g in RAG-1-/- mice. Studies will be performed to determine how these CD8+ cell- derived cytokines affect renal and vascular function and lead to end-organ damage. In preliminary studies for aim 2, we have found that angiotensin II infusion causes dendritic cell activation and that these activated dendritic cells stimulate T cells to proliferateand produce IL-17 and IFN-g.
In aim 2, we will gain further understanding of this by examining the subtype of dendritic cell involved and the sites of dendritic cell activation that are most importat for stimulation of CD8+ T cells. In preliminary studies for aim 3, we have found that angiotensin II infusion increases dendritic cell superoxide production by the NADPH oxidase. We propose experiments to understand how this contributes to hypertension and T cell activation by using mice with dendritic cell-specific deletion of the critical NADPH oxidase subunit p22phox. A potentially important effect of the formation of superoxide and other reactive oxygen species is formation of isoprostanes, which can rearrange to form highly reactive gamma ketoaldehydes or isoketals. These, in turn, can form covalent adducts with protein lysines and have myriad effects on cell function. We have preliminary data showing that isoketals are increased in tissues and dendritic cells by angiotensin II and that isoketal scavenging prevents hypertension.
In aim 4, we will test the hypothesis that isoketal formation in dendritic cells plays a major downstream role in dendritic cell immunogenicity, activation of CD8+ cells and ultimately in hypertension. These studies will provide new insight into the immune mechanisms of hypertension and its concomitant end-organ damage. Moreover, our studies with isoketal scavengers promise to provide a new therapeutic option for treatment of this devastating disease.

Public Health Relevance

High blood pressure is an enormous health care burden in the United States, affecting one in three adults. It is a major cause of stroke, heart attack and kidne disease;however, the causes of hypertension remain poorly understood and treatment is not always successful. In our proposed studies, we will further define the inflammation that causes hypertension and develop new strategies to prevent this.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL039006-24
Application #
8439226
Study Section
Hypertension and Microcirculation Study Section (HM)
Program Officer
Reid, Diane M
Project Start
1987-08-01
Project End
2018-01-31
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
24
Fiscal Year
2013
Total Cost
$390,000
Indirect Cost
$140,000
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Humphrey, Jay D; Harrison, David G; Figueroa, C Alberto et al. (2016) Central Artery Stiffness in Hypertension and Aging: A Problem With Cause and Consequence. Circ Res 118:379-81
Montaniel, Kim Ramil C; Harrison, David G (2016) Is Hypertension a Bone Marrow Disease? Circulation 134:1369-1372
Bersi, Matthew R; Bellini, Chiara; Wu, Jing et al. (2016) Excessive Adventitial Remodeling Leads to Early Aortic Maladaptation in Angiotensin-Induced Hypertension. Hypertension 67:890-6
Harrison, D G; Guzik, Tomasz J (2016) Macrophages come to mind as keys to cognitive decline. J Clin Invest 126:4393-4395
Wu, Jing; Saleh, Mohamed A; Kirabo, Annet et al. (2016) Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest 126:50-67
Wu, Jing; Montaniel, Kim Ramil C; Saleh, Mohamed A et al. (2016) Origin of Matrix-Producing Cells That Contribute to Aortic Fibrosis in Hypertension. Hypertension 67:461-8
Itani, Hana A; Xiao, Liang; Saleh, Mohamed A et al. (2016) CD70 Exacerbates Blood Pressure Elevation and Renal Damage in Response to Repeated Hypertensive Stimuli. Circ Res 118:1233-43
Itani, Hana A; McMaster Jr, William G; Saleh, Mohamed A et al. (2016) Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans. Hypertension 68:123-32
Wenzel, Ulrich; Turner, Jan Eric; Krebs, Christian et al. (2016) Immune Mechanisms in Arterial Hypertension. J Am Soc Nephrol 27:677-86
Saleh, Mohamed A; McMaster, William G; Wu, Jing et al. (2015) Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J Clin Invest 125:1189-202

Showing the most recent 10 out of 124 publications